How Much Weight Can You Expect to Lose on Ozempic?

Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, produces significant weight loss in most patients when combined with consistent nutrition and activity changes. Clinical evidence from the STEP trials demonstrated that participants using semaglutide lost between 15 and 22 percent of their starting body weight over approximately one year, though results depend on individual factors including genetics, adherence, and metabolic response.

Clinical Trial Weight Loss Data for Semaglutide

The landmark STEP 1 trial enrolled nearly 1,900 adults with obesity and tracked their weight loss over 68 weeks of treatment. Participants randomized to the highest semaglutide dose (2.4 mg weekly) achieved an average weight reduction of approximately 15.3 kg, or about 22% of baseline body weight. Those assigned to placebo lost only 2.6 kg on average, highlighting the medication's potent effect beyond diet and exercise alone.

Additional STEP trials (STEP 2, 3, and 4) confirmed these results across different patient populations, including those with type 2 diabetes and cardiovascular disease. Weight loss generally occurred within the first 16 weeks of treatment, with continued gradual reductions through the end of the study period. Importantly, most participants who continued semaglutide sustained their weight loss for at least one year, suggesting long-term benefit when treatment is maintained.

Factors That Influence Your Individual Weight Loss Results

Your genetic makeup significantly affects how your body responds to semaglutide and similar GLP-1 medications. Variations in genes controlling appetite signaling (such as GLP1R and GIPR pathways) and metabolism (including FTO and MC4R variants) determine whether you'll experience robust appetite suppression or a more modest response. PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides to reveal your individual predisposition to GLP-1 therapy, allowing personalized dose selection and compound choice.

Lifestyle factors including dietary adherence, physical activity level, sleep quality, and stress management directly impact weight loss outcomes. Patients who combine semaglutide with consistent calorie reduction and moderate exercise achieve greater total weight loss than those relying on medication alone. Starting body weight, age, baseline metabolic rate, and previous weight loss attempts also influence both the speed and magnitude of your response.

How Dose Escalation Affects Weight Loss Progress

Semaglutide treatment typically begins at a low dose (0.25 mg weekly) to allow your body to adjust and minimize gastrointestinal side effects. Over 4 to 8 weeks, your dose increases gradually—stepping up to 0.5 mg, then 1.0 mg, then 1.7 mg, and finally 2.4 mg—each increase allowing further appetite reduction and enhanced metabolic effect. Most significant weight loss occurs after reaching your optimal maintenance dose, which may differ from the standard target depending on your tolerance and genetic response profile.

PlexusDx ensures your dose escalates based on your individual tolerance and treatment goals rather than a preset timeline. Your dose may need to go up—your price won't. Compounded Semaglutide Injection starts at $149 per month regardless of which dose level you're using, removing financial barriers to optimal dosing. This flat pricing model ensures you can stay on the most effective dose for your metabolism without cost escalation.

Timeline: When to Expect Weight Loss on Semaglutide

Most patients begin noticing reduced hunger and mild appetite suppression within the first 7 to 10 days of starting semaglutide, even at the lowest dose. Measurable weight loss typically appears by week 4 to 6, with an average loss of 2 to 4 pounds per month during the initial dose escalation phase. Weight loss continues to accelerate as you reach higher maintenance doses, with the steepest weight loss generally occurring between weeks 8 and 24 of treatment.

By week 16 of consistent treatment at therapeutic doses, most patients have achieved 10 to 15 pounds of weight loss. By month 6, average cumulative loss reaches 15 to 20 pounds, and by one year, many patients report total losses of 25 to 50 pounds or more depending on starting weight and adherence. Plateaus may occur after 6 to 12 months, at which point your healthcare provider may adjust your dose, compound, or recommend lifestyle intensification.

Real-World Weight Loss Beyond Clinical Trials

Clinical trial populations differ from real-world patients in important ways—trial participants often receive intensive dietary counseling, close monitoring, and higher adherence rates than typical clinical practice. Real-world weight loss on semaglutide varies more widely, with some patients achieving 20-30% weight reduction while others lose 10-15% of body weight. This variation reflects differences in genetic response, lifestyle integration, dose tolerance, and consistency of medication use.

PlexusDx patients benefit from access to compounded semaglutide at transparent, flat pricing ($149-$189/month across commitment tiers) without insurance requirements, making consistent treatment more affordable and accessible. The Precision Peptide Genetic Test ($99 add-on) identifies your metabolic phenotype before treatment intensification, helping your provider choose whether semaglutide alone, tirzepatide, or dual-compound GLP-Squared therapy will deliver optimal results for your unique peptide pathways.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What's the average weight loss on semaglutide per month?

Most patients lose 2-4 pounds monthly during initial dose escalation, with cumulative monthly averages reaching 3-5 pounds as doses increase toward the 2.4 mg maintenance level. Total losses vary widely based on baseline weight, genetics, diet adherence, and activity level, but clinical trials show approximately 15-22% total body weight loss over one year.

Will I lose weight faster at higher semaglutide doses?

Yes, clinical evidence shows greater appetite suppression and weight loss at higher doses (1.7-2.4 mg weekly) compared to lower doses (0.25-0.5 mg). However, individual genetic variation means some patients reach optimal results at moderate doses while others benefit from maximum dosing—this is where the Precision Peptide Genetic Test helps personalize your therapy.

How much does PlexusDx compounded semaglutide cost?

PlexusDx Compounded Semaglutide Injection starts at $149 per month and remains flat across all dose levels—your dose may need to go up, your price won't. This pricing applies across three commitment tiers ($149-$189/month), with no insurance required and HSA/FSA eligibility available.

What if I don't lose weight on semaglutide?

Non-response to semaglutide occurs in roughly 5-10% of patients and often reflects genetic factors limiting GLP-1 receptor activation. PlexusDx addresses this by offering tirzepatide (which activates both GLP-1 and GIP pathways) or GLP-Squared dual-compound therapy, which may overcome genetic resistance—the Precision Peptide Genetic Test identifies these predispositions upfront.

How does the Precision Peptide Genetic Test improve my weight loss results?

PlexusDx's Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, MC4R, and 10 additional metabolic pathways controlling 49 peptides to predict your individual response intensity and optimal compound choice. This $99 add-on (available after your first month) guides whether semaglutide alone, tirzepatide, or dual-compound therapy will maximize your weight loss potential before dose adjustments.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Ozempic For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.